Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing v3.6.0, indicating a minor revision to the page. This update appears to be a metadata/backend adjustment rather than a change to study content or user-facing details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe study details page now indicates that recruitment has ended, signaling that participants are no longer being sought. In addition, the page introduces new help/navigation items and normalizes the Intervention/Treatment header, along with an updated revision label to reflect the latest version.SummaryDifference0.4%

- Check26 days agoChange DetectedThe page's revision history now includes Revision: v3.5.5 and removes Revision: v3.5.4. This reflects a version-control update to the page, without changes to the study data or displayed information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new build of the site rather than an alteration to study information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, without changing the displayed study details.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated to v3.5.2 and the previous revision v3.5.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.